Ardelyx Gets IBS-C Approval, But Focus Remains On Hyperphosphatemia
Executive Summary
Tenapanor approved for IBS-C as Ibsrela, but Ardelyx is still seeking a commercial partner for that indication – and is maintaining focus on same molecule in hyperphosphatemia.